Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

Objectives: We aimed to evaluate the drug retention rate and safety of secukinumab (SEC) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) in a real clinical setting. Methods: This multicenter retrospective observational study included all AxSpA and PsA patients who rece...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Main Authors: Alonso, Sara, Villa, Ignacio, Fernández, Sabela, Martín, José L., Charca, Lilyan, Pino, Marina, Riancho, Leyre, Morante, Isla, Santos, Monserrat, Brandy, Anahy, Aurrecoechea, Elena, Carmona, Loreto, Queiro, Rubén
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8187784/
https://ncbi.nlm.nih.gov/pubmed/34124110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.679009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares